SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-028774
Filing Date
2023-10-23
Accepted
2023-10-23 17:01:03
Documents
14
Period of Report
2023-10-18
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vxrt20231020_8k.htm   iXBRL 8-K 34706
2 EXHIBIT 3.1 ex_584587.htm EX-3.1 124445
  Complete submission text file 0001437749-23-028774.txt   325980

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vxrt-20231018.xsd EX-101.SCH 3410
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vxrt-20231018_def.xml EX-101.DEF 11805
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vxrt-20231018_lab.xml EX-101.LAB 15849
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vxrt-20231018_pre.xml EX-101.PRE 12020
8 EXTRACTED XBRL INSTANCE DOCUMENT vxrt20231020_8k_htm.xml XML 2650
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 231340473
SIC: 2836 Biological Products, (No Diagnostic Substances)